Depot Disulfiram for AIDS and ARC
Launched by ST. VINCENT'S MEDICAL CENTER · Aug 30, 2001
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria.
- * Also patient must be:
- • Able to understand the study.
- • Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms.
- • Ambulatory and able to maintain an independent life outside the hospital.
- • Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
- • Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
- • Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
- • History of alcohol abuse.
About St. Vincent's Medical Center
St. Vincent's Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a part of a comprehensive network of care, the center offers a multidisciplinary approach to research, collaborating with experts across various specialties to explore new therapies and treatment methodologies. With a commitment to ethical standards and patient safety, St. Vincent's Medical Center aims to contribute to the scientific community while providing patients access to cutting-edge clinical options. Their focus on compassionate care and rigorous research positions them as a trusted sponsor in the clinical trial landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Staten Island, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials